Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up survey comparing stable Seretide dosing versus symptom-based as-needed Symbicort in persistent asthma
2008-006768-13Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salmeterol + fluticasone and budesonide in asthma and persistent asthma (2 arms), sponsored by GSK. Started Oct 2008; status: completed.
02
Drugs
salmeterol + fluticasonebudesonide
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2008-006768-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006768-13.